{
 "drug": "Plerixafor Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "03/13/2026",
 "dayN": 165,
 "cat": "Hematology",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "03/13/2026",
   "update_type": "New",
   "initial_posting_date": "03/13/2026",
   "package_ndc": "65219-284-12",
   "generic_name": "Plerixafor Injection",
   "contact_info": "888-391-6300 www.fresenius-kabi.com",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA022311"
    ],
    "brand_name": [
     "PLERIXAFOR"
    ],
    "generic_name": [
     "PLERIXAFOR"
    ],
    "manufacturer_name": [
     "Fresenius Kabi Usa, LLC"
    ],
    "product_ndc": [
     "65219-284"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "PLERIXAFOR"
    ],
    "rxcui": [
     "828700"
    ],
    "spl_id": [
     "ba468eca-fb47-497b-8aed-a1576249ea6a"
    ],
    "spl_set_id": [
     "5d670cb4-163e-498c-b5fa-c193ea9d55c0"
    ],
    "package_ndc": [
     "65219-284-12"
    ],
    "nui": [
     "N0000178326",
     "N0000178324"
    ],
    "pharm_class_epc": [
     "Hematopoietic Stem Cell Mobilizer [EPC]"
    ],
    "pharm_class_pe": [
     "Increased Hematopoietic Stem Cell Mobilization [PE]"
    ],
    "unii": [
     "S915P5499N"
    ]
   },
   "update_date": "03/13/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}